Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 227 results found. Search for [ COVAXIN ]

Results 1 to 21 of 227
BusinessToday.In
December 2, 2020
Union health secretary Rajesh Bhushan says the adverse event during recent clinical trials will not affect the timelines in any manner whatsoever


BusinessToday.In
November 30, 2020
PM Modi asks teams to come out with ideas on regulatory processes and related matters. As pharma companies move ahead with their clinical trials, the government has also stepped up efforts to devise the vaccine distribution plan


BusinessToday.In
November 30, 2020
There are only five companies that have given preliminary data about how effective their vaccines could be to fight against coronavirus. These five companies include Pfizer-BioTech, Moderna Inc, Oxford University-AstraZeneca Plc, and Gamaleya Institute


BusinessToday.In
November 28, 2020
PM Modi paid his visit to Pune-based Serum Institute of India and reviewed the manufacturing process of COVID-19 vaccine. He interacted with scientists at the SII and went around the facility, taking stock of vaccine development work


PTI
November 28, 2020
PM Modi landed at Hakimpet Air Force station near here at around 1 pm,as part of his three-city tour to take the stock of COVID-19 vaccine development


BusinessToday.In
November 28, 2020
PM Modi took stock of the work being done so far on the development of coronavirus vaccine at the Zydus Cadila research centre


PB Jayakumar
November 28, 2020
Prime Minister Narendra Modi's visit to these facilities and discussions with the scientists are to help him get a first-hand perspective of the preparations, challenges and roadmap in India's vaccination plans


BusinessToday.In
November 27, 2020
After the publication of early data from phase-3 clinical trials, drugmakers Pfizer and BioNTech have sought regulatory approval to deploy their inoculation under emergency-use rules. American biotech company Moderna is also likely to do the same soon


BusinessToday.In
November 25, 2020
The speed is going to be that of a very severe cyclonic storm, which is 130-145kmph with gusting winds. Earlier, it was anticipated that the cyclone would peak on Wednesday, with gusting winds at 110 kmph.


BusinessToday.In
November 25, 2020
Indian drug regulator may provide an emergency approval to AstraZeneca's COVID-19 vaccine by end-December or early January 21, says Nomura


PB Jayakumar & Joe C Mathew
New Delhi, November 25, 2020
A blow-by-blow account of how Indian vaccines are being readied


BusinessToday.In
November 24, 2020
The cyclonic storm Nivar is expected to intensify further, clocking wind speeds in the range of 100-110 kmph, gusting to 120 kmph.


BusinessToday.In
November 24, 2020
Vardhan says it makes no sense to consider Pfizer as pharma major is yet to get approval in the US. After requisite approvals, US pharma major will have to cater to needs of its own country's population first


BusinessToday.In
November 23, 2020
SpiceHealth has signed a Memorandum of Understanding with the Indian Council of Medical Research for setting up testing facilities and collection centres across the nation.


BusinessToday.In
November 23, 2020
The panel-led by Dravida Munnetra Kazhagam (DMK) lawmaker Kanimozhi Karunanidhi will hear officials of pharmaceutical departments on the status of the COVID-19 vaccine


BusinessToday.In
November 23, 2020
Coronavirus vaccine update: Adar Poonawalla, the CEO of Serum Institute had recently said that his company might sell a two-shot COVID-19 vaccine for around Rs 500-600 for the general public


BusinessToday.In
November 23, 2020
The Prime Minister is expected to hold two back-to-back meetings, one with those states with high caseloads and another related to vaccine distribution strategy.


BusinessToday.In
November 22, 2020
RIL, TCS, and Infosys suffered an erosion in their m-cap for the week ended Friday. However, HDFC Bank, HDFC Ltd, Bajaj Finance Ltd and Bharti Airtel finished with gains


BusinessToday.In
November 22, 2020
Bharat Biotech has started the phase- 3 trial of its potential COVID-19 vaccine, involving 26,000 volunteers this month across 25 centres in the country, including Hyderabad, Goa, Nagpur, Bhubaneswar, and Aligarh


Reuters
November 22, 2020
The agency said the antibodies are not authorized for patients who are hospitalized due to COVID-19 or require oxygen therapy due to COVID-19


PAGES 1 OF 12  12345